CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a human chymase inhibitor.
CH 5450 is a synthetic small molecule that functions as a potent and selective phosphodiesterase 4 (PDE4) inhibitor. As a research tool, it has garnered significant interest in the fields of biochemistry, pharmacology, and molecular biology due to its ability to modulate intracellular cyclic adenosine monophosphate (cAMP) signaling pathways. By inhibiting PDE4, CH 5450 prevents the breakdown of cAMP, a critical second messenger involved in diverse cellular processes such as gene expression, cell proliferation, and inflammatory responses. Its specificity and well-characterized mechanism make it a valuable compound for dissecting cAMP-dependent signaling cascades and for investigating the roles of PDE4 isoforms in various biological systems.
Signal transduction research: CH 5450 is widely utilized in studies focusing on cAMP-mediated signaling pathways. By selectively inhibiting PDE4, it enables researchers to elevate intracellular cAMP levels in a controlled manner, facilitating the dissection of downstream effectors such as protein kinase A (PKA) and exchange proteins directly activated by cAMP (EPAC). This approach is instrumental in elucidating the molecular mechanisms underlying cAMP-dependent gene transcription, protein phosphorylation events, and the fine-tuning of cellular responses to external stimuli.
Inflammatory response modulation: The compound serves as an important tool for investigating the biochemical basis of inflammatory processes. PDE4 is highly expressed in immune cells including monocytes, macrophages, and T lymphocytes, where it regulates the degradation of cAMP. By blocking PDE4 activity, CH 5450 can be used to probe the effects of sustained cAMP elevation on the production of pro-inflammatory cytokines and chemokines. Such studies are crucial for understanding the molecular interplay between cAMP signaling and immune cell activation, providing insights into the regulation of inflammatory gene expression.
Neuroscience and neuropharmacology: In neurobiological research, CH 5450 is employed to study the role of cAMP signaling in neuronal function, synaptic plasticity, and neuroinflammation. PDE4 isoforms are abundantly expressed in the central nervous system, and their inhibition has been linked to alterations in neurotransmitter release, long-term potentiation, and neuroprotective signaling. Utilizing this compound allows researchers to model the effects of enhanced cAMP signaling in neuronal cultures or brain tissue preparations, advancing the understanding of how cyclic nucleotide pathways influence neural circuitry and cognitive processes.
Cellular proliferation and differentiation studies: The ability to modulate cAMP levels with a selective PDE4 inhibitor provides a powerful approach for examining the impact of cyclic nucleotide signaling on cell growth and differentiation. CH 5450 is used in experimental systems to assess how elevated cAMP affects the cell cycle, apoptosis, and lineage commitment in various cell types, including epithelial cells, fibroblasts, and hematopoietic progenitors. These investigations contribute to a broader comprehension of how second messenger systems orchestrate complex cellular behaviors during development and tissue remodeling.
Pharmacological profiling and drug discovery: As a well-characterized PDE4 inhibitor, CH 5450 is frequently incorporated into compound screening assays and structure-activity relationship (SAR) studies. It serves as a reference molecule for benchmarking the potency, selectivity, and functional consequences of novel PDE4-targeted agents. Its inclusion in in vitro pharmacological assays helps delineate the specificity of candidate molecules, supports target validation efforts, and facilitates the optimization of next-generation modulators of cyclic nucleotide signaling for research applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More